COSM: financial statements from SEC — TradeAlmanac

COSM

Cosmos Health Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	65m	54m
Cost of revenue	57m	50m
Gross profit	8m	4m
Research and development	519,363	533,293
Selling, general and administrative	16m	12m
Operating expenses	25m	20m
Operating income	−17m	−16m
Interest expense	2m	1m
Pre-tax income	−19m	−16m
Income tax	0	0
Net income	−19m	−16m
Earnings per share	−0.63	−1.17
Earnings per share, diluted	−0.63	−1.17
Weighted average shares	30m	19m
Weighted average shares, diluted	30m	19m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	514,702	715,674	889,441	655,503	742,881	315,105	3m	343,509
Short-term investments	34,225	46,158

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	−8m	−8m
Depreciation and amortisation	1m	1m
Share-based compensation	2m	2m
Capital expenditure	55,675	418,075
Investing cash flow	−2m	−798,269
Share buybacks

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)